Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy

被引:3
|
作者
Rao, Anirudh [1 ,2 ]
Singh, Manavotam [3 ]
Maini, Mansi [1 ]
Anderson, Kelley M. M. [4 ]
Crowell, Nancy A. A. [4 ]
Henderson, Paul R. R. [1 ]
Gholami, Sherry S. S. [1 ]
Sheikh, Farooq H. H. [1 ,3 ]
Najjar, Samer S. S. [3 ]
Groninger, Hunter [1 ,2 ]
机构
[1] Georgetown Univ, Sch Med, Dept Med, Washington, DC 20007 USA
[2] MedStar Washington Hosp Ctr, Dept Med, Sect Palliat Med, Washington, DC 20010 USA
[3] MedStar Heart & Vasc Inst, MedStar Washington Hosp Ctr, Washington, DC USA
[4] Georgetown Univ, Sch Nursing & Hlth Studies, Washington, DC USA
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
关键词
inotropes; Stage D heart failure; palliative care; LVAD; heart transplant; HEART-FAILURE; FRAILTY; GUIDELINES; CRITERIA; SOCIETY;
D O I
10.3389/fcvm.2022.918146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundMany patients with advanced heart failure (HF) are administered chronic intravenous inotropic support (CIIS) as bridge to surgical therapy; some ultimately never receive surgery. We aimed to describe reasons patients "crossover" from CIIS as bridge therapy to palliative therapy, and compare end-of-life outcomes to patients initiated on CIIS as palliative therapy. MethodsSingle-institution, retrospective cohort study of patients on CIIS as bridge or palliative therapy between 2010 and 2016; data obtained through review of health records and multi-disciplinary selection meeting minutes, was analyzed using descriptive and inferential statistics. ResultsOf 246 patients discharged on CIIS as bridge therapy, 37 (16%) (male n = 28, 76%; African American n = 22, 60%) ultimately never received surgery. 67 matched patients on CIIS as palliative therapy were included for analysis (male n = 47, 70%; African American n = 47, 70%). The most common reasons for "crossover" from CIIS as bridge therapy to palliative therapy were frailty (n = 10, 27%), cardiac arrest (n = 5, 13.5%), and progressive non-cardiac illnesses (n = 6, 16.2%). A similar percentage of patients in the bridge (n = 28, 76%) and palliative (n = 48, 72%) groups died outside the hospital (P=0.66); however, fewer bridge patients received hospice care compared to the palliative group (35% vs 69%, P < 0.001). Comparing patients who died in the hospital, bridge patients (n = 9; 100%) were more likely to die in the intensive care unit than palliative patients (n = 8; 42%) (P < 0.001). ConclusionPatients on CIIS as bridge therapy who do not ultimately receive surgical therapy "crossover" to palliative intention due to frailty, or development of or identification of serious illnesses. Nevertheless, these "bridge to nowhere" patients are less likely to receive palliative care or hospice and more likely to die in the intensive care unit than patients on CIIS as palliative therapy.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study
    Xiao Hou
    Li Tian
    Lei Zhou
    Xinhua Jia
    Li Kong
    Yitao Xue
    Hao Hao
    Xianqing Meng
    Feihu Zhang
    Xiaobin Dong
    Virology Journal, 18
  • [22] Risk factors for mortality in surgical patients on combined continuous renal replacement therapy and extracorporeal membrane oxygenation: single-center retrospective study
    Huang, Suiqing
    Wang, Junjie
    Feng, Kangni
    Wu, Huawei
    Shang, Liqun
    Huang, Yang
    Zhou, Zhuoming
    Li, Huayang
    Liu, Quan
    Chen, Jiantao
    Liang, Mengya
    Hou, Jian
    Chen, Guangxian
    Wu, Zhongkai
    RENAL FAILURE, 2023, 45 (02)
  • [23] Experience of Continuous Renal Replacement Therapy in Critically Ill Patients With AKI: A Single-Center Retrospective Study
    Diaz Garcia, Juan D.
    Lopez, Claudia B.
    Ramirez, Irving G.
    Nieto, Julio C.
    Morales Molina, Pedro
    Prado, Pamela
    Cerezo Samperio, Beatriz R.
    Compean, Abel Humberto V.
    Chimbo Lituma, Karina
    Alamilla Sanchez, Mario
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 900 - 900
  • [24] The effectiveness of adjuvant therapy in adult patients with spindle cell/sclerosing rhabdomyosarcoma: A single-center retrospective study
    Liu, Zijing
    Liu, Jie
    Deng, Yaotiao
    Jiang, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Timing of Antibiotic Therapy in Hospitalized Patients With Clostridium difficile Infection: A Single-Center Retrospective Cohort Study
    Skef, Wasseem
    Daglilar, Ehubekir S.
    Jaber, Bertrand L.
    Nader, Claudia
    Hamilton, Matthew J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S559 - S559
  • [26] Real-life practice of antiviral therapy and disease patterns of patients with chronic hepatitis B: a single-center retrospective observation study
    Jie, Yusheng
    Li, Xiangyong
    Lin, Guoli
    Wu, Yuankai
    Li, Xinhua
    Gao, Zhiliang
    Chong, Yutian
    HEPATOLOGY INTERNATIONAL, 2014, 8 (04) : 501 - 507
  • [27] Real-life practice of antiviral therapy and disease patterns of patients with chronic hepatitis B: a single-center retrospective observation study
    Yusheng Jie
    Xiangyong Li
    Guoli Lin
    Yuankai Wu
    Xinhua Li
    Zhiliang Gao
    Yutian Chong
    Hepatology International, 2014, 8 : 501 - 507
  • [28] Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure
    Hauptman, PJ
    Woods, D
    Pritzker, MR
    CLINICAL CARDIOLOGY, 2002, 25 (05) : 247 - 249
  • [29] Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study
    Sofia Jönsson
    Bob Olsson
    Jenny Söderberg
    Hans Wadenvik
    Annals of Hematology, 2012, 91 : 679 - 685
  • [30] Response to imatinib therapy in adult patients with chronic myeloid leukemia in Saudi population: a single-center study
    Alsobhi, Enaam
    Abrar, Mohammed Burhan
    Abdelaal, Mohammed
    Alsaeed, Ahmed
    Absi, Ahmed
    Alzahrani, Zayed
    El-Hennaidi, Lhab
    Alshehri, Mohammed Ali
    Warsi, Ashraf
    Bayashoot, Safaa
    Hashem, Heba
    Merdad, Anas
    Radi, Suhaib
    Shiekhi, Hanadi
    Al-Amri, Abdulfattah
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 882 - 886